Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-17

Clinical Trial Update: Suramin and Paclitaxel in Treating Women With Stage IIIB-IV Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 1/2 study of suramin in combination with paclitaxel for women with stage IIIB to IV breast cancer, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PACLITAXEL (PACLITAXEL)
  • Suramin (suramin)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Breast Cancer, Stage IIIB Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-03-17